全文获取类型
收费全文 | 6569篇 |
免费 | 474篇 |
国内免费 | 154篇 |
专业分类
耳鼻咽喉 | 92篇 |
儿科学 | 94篇 |
妇产科学 | 106篇 |
基础医学 | 336篇 |
口腔科学 | 66篇 |
临床医学 | 330篇 |
内科学 | 569篇 |
皮肤病学 | 61篇 |
神经病学 | 116篇 |
特种医学 | 503篇 |
外国民族医学 | 3篇 |
外科学 | 1272篇 |
综合类 | 454篇 |
预防医学 | 63篇 |
眼科学 | 35篇 |
药学 | 188篇 |
1篇 | |
中国医学 | 40篇 |
肿瘤学 | 2868篇 |
出版年
2024年 | 11篇 |
2023年 | 105篇 |
2022年 | 190篇 |
2021年 | 269篇 |
2020年 | 237篇 |
2019年 | 236篇 |
2018年 | 253篇 |
2017年 | 197篇 |
2016年 | 276篇 |
2015年 | 263篇 |
2014年 | 406篇 |
2013年 | 465篇 |
2012年 | 338篇 |
2011年 | 312篇 |
2010年 | 234篇 |
2009年 | 331篇 |
2008年 | 353篇 |
2007年 | 357篇 |
2006年 | 306篇 |
2005年 | 265篇 |
2004年 | 219篇 |
2003年 | 170篇 |
2002年 | 153篇 |
2001年 | 153篇 |
2000年 | 112篇 |
1999年 | 114篇 |
1998年 | 120篇 |
1997年 | 86篇 |
1996年 | 58篇 |
1995年 | 68篇 |
1994年 | 65篇 |
1993年 | 47篇 |
1992年 | 48篇 |
1991年 | 31篇 |
1990年 | 25篇 |
1989年 | 40篇 |
1988年 | 37篇 |
1987年 | 18篇 |
1986年 | 34篇 |
1985年 | 30篇 |
1984年 | 28篇 |
1983年 | 16篇 |
1982年 | 24篇 |
1981年 | 26篇 |
1980年 | 25篇 |
1979年 | 19篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1972年 | 2篇 |
排序方式: 共有7197条查询结果,搜索用时 15 毫秒
91.
目的探讨关于骨转移瘤常规分割放疗组与低分割放疗组的止痛效果。方法48例病人,28例采用常规分割,DT200CGY/次,每周5次,DT3000~5000CGY;20例采用低分割照射,DT400~500CGY/次,每周2~3次,DT2500~3000CGY。结果放疗起到了明显的止痛作用,常规分割放疗组与低分割放疗组止痛效果大致相同,无统计学意义(P>0.05)。结论放疗原则应根据病情及预计生存期长短来决定。对一般情况好,预计生存期长的病人应采取积极的治疗,给予大剂量长疗程的常规分割,而对于那些病情相对较重,行动又不方便,无望长期生存的病人,应采取低分割照射,且见效快,同样起到止痛作用 相似文献
92.
目的 评价 1 53钐 -乙二胺四亚甲基膦酸盐 (1 53Sm- EDTMP)与 99m Tc亚甲基二膦酸盐 (商品名云克 )联合应用治疗多发性骨转移癌的疗效。方法 各种骨转移癌 132例 ,随机分组治疗 ,第 1组 4 2例患者仅静脉注射 1 53Sm- EDTMP,1.0× 10 7Bq/ kg,第 2组 5 0例患者 1 53Sm- EDTMP联合 99m Tc亚甲基二膦酸盐治疗 ,1 53Sm- EDTMP用量不变 ,并与静脉注射 1 53Sm- EDTMP后的第 5天开始用 99m Tc亚甲基二膦酸盐连续 5 d。第 3组 4 0例患者静脉滴注博宁 ,10 d1个疗程。结果 第 1组镇痛有效率为 6 1% ,疼痛缓解持续时间平均 4周。第 2组联合用药组镇痛有效率达 80 % ,疼痛缓解持续时间平均 8周。第 3组镇痛有效率 4 2 % ,疼痛缓解持续时间平均 2周。 3组疗效有显著统计学意义 (P<0 .0 5 )。结论 不论 1 53Sm - EDTMP单独使用还是与 99m Tc亚甲基二膦酸盐联合用药都是治疗多发骨转移的有效止痛方法 ,相比之下 ,联合用药可明显提高镇痛效率。 相似文献
93.
Effect of HIF-1α on VEGF-C Induced Lymphangiogenesis and Lymph Nodes Metastases of Pancreatic Cancer 总被引:4,自引:0,他引:4
The effect of hypoxia inducible factor-1α(HIF-1α) on vascular endothelial growth factor C (VEGF-C) and the correlation between HIF-1αand lymphangiogenesis and lymph nodes metasta-ses (LNM) in pancreatic cancer were investigated. Immunohistochemical SP method was used to detect the protein expression of HIF-1αand VEGF-C, and Lymphatic vessel density (LVD) was determined by stain of VEGFR-3, collagen type IV in 75 pancreatic head cancers from regional pancre-atectomy (RP) during Dec. 2001 to Dec. 2003. The relationship between HIF-1αand VEGF-C, lymphangiogenesis, LNM was analyzed statistically. The results showed that the positive expression rate of HIF-1αand VEGF-C in pancreatic cancer tissues was 48.00 % (36/75) and 65.33 % (49/75) respectively. In positive group of HIF-1α, the positive rate of VEGF-C and LVD, and LVD rate was 80.56 % (29/36), 13.22±3.76 and 88.89 % (32/36) respectively, and in negative group of HEF-1α, positive rate of VEGF-C and LVD was 51.28 % (20/39), 5.98±2.17 and 66.67 % (26/39) respectively (P<0.01 or P<0.05). It was suggested that HIF-1αcould promote the expression of VEGF-C, lymphangiogenesis and LNM in pancreatic cancer. 相似文献
94.
E. KASTRITIS E. EFSTATHIOU D. GIKA G. BOZAS V. KOUTSOUKOU C. PAPADIMITRIOU G. PISSAKAS† M.A. DIMOPOULOS & A. BAMIAS 《International journal of gynecological cancer》2006,16(3):994-999
Brain metastases in patients with epithelial ovarian cancer (EOC) have an estimated incidence of 0.3-1.9% and are isolated in up to 50% of these patients. The risk factors and the prognostic significance of isolated central nervous system (CNS) relapse in patients with EOC who received primary treatment with platinum and paclitaxel have not been identified. We conducted a retrospective study in patients with EOC who relapsed with isolated brain metastases and report our experience. Two hundred sixty-seven patients with stages III and IV EOC, in clinical complete remission after first-line treatment with platinum and paclitaxel, were included in our analysis. After a median follow-up of 65 months, 150 patients had relapsed. Eight patients (5%) had isolated brain metastases. Patient and disease characteristics did not differ among patients who relapsed with isolated brain metastases and those with relapse outside the CNS. Median time to first disease relapse, overall survival, and survival after relapse did not differ significantly between patients with brain metastases and those with relapse outside the CNS. Two patients have died 6 and 12 months after the diagnosis of brain metastases, and 5 patients are alive 4-35 months after the diagnosis of isolated brain metastases. Three patients remain free of disease 4-18 months after treatment with radiotherapy and systemic chemotherapy for their CNS metastatic disease. Patients with isolated brain metastases have comparable survival to patients with relapse outside the CNS, and long-term remission can be achieved in some cases, provided that systemic chemotherapy is added to local treatment. 相似文献
95.
96.
nm23-H1基因表达与鼻咽癌的早发转移 总被引:4,自引:0,他引:4
目的探讨nm23-H1基因产物的表达与鼻咽癌早发转移的关系.方法应用免疫组化S-P法对95例鼻咽癌组织蜡块进行nm23-H1检测.结果nm23-H1的阳性表达率为47.4%(45/95),早发转移组nm23-H1阳性率(26.7%)低于无转移组(60.0%),差异有统计学意义(P<0.05).nm23-H1表达与临床分期无关.结论nm23-H1阴性表达与鼻咽癌早发转移有关,nm23-H1的表达水平可能是预测中晚期鼻咽癌远处转移的一个重要的生物学指标. 相似文献
97.
目的:探讨卵巢上皮癌治疗后远处转移的影响因素。方法:对我院1990年1月5日~1995年12月10日收治的40例卵巢上皮癌远处转移者进行回顾分析。结果:初次手术后残余癌灶≤2cm和〉2cm者远处转移率分别为32.5%和60%。全身化疗〈4个疗程和≥4个疗程者转移率分别为62.5%和37.5%,有腹水者和无腹水者的转移率分别为65%和36%P〈0.05。结论:卵巢上皮癌初次治疗后残余癌灶大小、化疗疗程、有恶性腹水者是远处转移的重要因素。 相似文献
98.
Hongyi Cai Xiaohu Wang Huiping Cao Xiaoqi Wang Xiaodong Liu Zhiyong Zhang Xinchun Dong 《中国肿瘤临床(英文版)》2005,2(4):737-743
OBJECTIVE Vertebral metastases are a common manifestation in patients with advanced cancer and treatment is often ineffective. This study was conducted to explore the efficacy of treating vertebral metastases by percutaneous vertebroplasty (PVP) combined with interventional chemotherapy. METHODS Seventy-five patients with vertebral metastases (42 men, 33 women; ages 31-76 years) were divided into 2 groups: 39 cases were treated by PVP combined with chemotherapy (VPCC group), and 36 cases were treated by PVP alone (VP group). All procedures were guided by computed tomography (CT) scanning. The results and complications were evaluated by a questionnaire regarding pain and routine follow-up. RESULTS The response rate was significantly higher in the VPCC group than in the VP group (93.0% vs 74.4%, P〈0.05); total response rates for the VPCC and VP groups were 25.6% and 10.3% respectively. A common complication related to VPCC was transient aggravating pain. CONCLUSION PVP may ameliorate pain, and consolidate the vertebrae of patients with vertebral metastases. Its short-term effect may be enhanced by adding drugs into the bone cement. 相似文献
99.
JI Tang M Back T Shakespeare JJ Lu R Mukherjee C Wynne S Liang 《Journal of Medical Imaging and Radiation Oncology》2005,49(5):390-395
The aims were to determine the median survival and prognostic factors of patients with central nervous system (CNS) metastases managed with whole‐brain radiation therapy (WBRT), and to explore selection criteria in recently published clinical trials using aggressive interventions in CNS metastases. A retrospective audit was performed on patients managed with WBRT for CNS metastases. Potential prognostic factors were recorded and analysed for their association with survival duration. The proportion of patients with these factors was also compared with those of patients managed under three recently reported studies investigating aggressive interventions, such as radiosurgery and chemotherapy for CNS metastases. Seventy‐three patients were treated with WBRT for cerebral metastases over a 12‐month period. The median survival of the population was 3.4 months (95% confidence interval: 2.7–4.1), with 6‐ and 12‐month survival rates of 30 and 18%, respectively. Significant prognostic factors for prolonged median survival were Eastern Cooperative Oncology Group status 0–2 (P = 0.015), Medical Research Council neurological functional status 0–1 (P = 0.006), and Recursive Partitioning Analysis Class 2 versus Class 3 (P = 0.020). On multivariate analysis, younger patient age (P = 0.02) and better performance status (P < 0.01) were associated with improved outcome. When comparing these characteristics with selected published studies, our study cohort demonstrated a higher proportion of patients with poor performance status, a greater number of metastases per patient and a higher incidence of extracranial disease. This reflects the selected nature of patients in these published studies. Central nervous system metastases confer a poor prognosis and, for the majority of patients, aggressive interventions are unlikely to improve survival. The use of potentially toxic and expensive treatments should be reserved for those few in whom these studies have shown a potential benefit. 相似文献
100.
《The African Journal of Urology》2016,22(4):253-255
Cutaneous metastases are an unusual location of a bladder tumor. We report through this observation the case of a patient with cutaneous metastases two years after cystoprostatectomy with bilateral cutaneous ureterostomy. 相似文献